Key result
Faster platelet inhibition remains under evaluation for improving clinical outcomes in AMI with cardiogenic shock.
Key points are not available for this paper at this time.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Grand et al. (2025) studied this question. Faster and more complete platelet inhibition in acute myocardial infarction with cardiogenic shock is being evaluated to determine if it translates to improved clinical outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: